Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 27, 2022
Characterizing HIV-Preventive, Plasma Tenofovir Concentrations-A Pooled Participant-level Data Analysis From Human Immunodeficiency Virus Preexposure Prophylaxis Clinical Trials
Maria Garcia-Cremades, Katarina Vučićević, Craig W Hendrix, et al.
Oncogene
|
October 1, 2022
Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment
Francesca Battaglin, Priya Jayachandran, Carly Strelez, et al.
International Journal of Molecular Sciences
|
March 27, 2025
Genetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal Cancer
Pooja Mittal, Francesca Battaglin, Yan Yang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 24, 2022
Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials
Jingyuan Wang, Yi Xiao, Fotios Loupakis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 7, 2012
Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features
Daniel T Chang, Rish K Pai, Lisa A Rybicki, et al.
Oncogene
|
January 17, 2023
Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions
Priya Jayachandran, Francesca Battaglin, Carly Strelez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 2022
Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer
Giacomo Mazzoli, Romain Cohen, Sara Lonardi, et al.
Journal for Immunotherapy of Cancer
|
January 2, 2023
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer
Vincenzo Nasca, Francesco Barretta, Francesca Corti, et al.
Journal for Immunotherapy of Cancer
|
January 4, 2025
Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors
Julien Taieb, Margherita Ambrosini, Emily Alouani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 29, 2021
Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women
Jyoti S Mathad, Rada Savic, Paula Britto, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 27, 2022
Characterizing HIV-Preventive, Plasma Tenofovir Concentrations-A Pooled Participant-level Data Analysis From Human Immunodeficiency Virus Preexposure Prophylaxis Clinical Trials
Maria Garcia-Cremades, Katarina Vučićević, Craig W Hendrix, et al.
Oncogene
|
October 1, 2022
Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment
Francesca Battaglin, Priya Jayachandran, Carly Strelez, et al.
International Journal of Molecular Sciences
|
March 27, 2025
Genetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal Cancer
Pooja Mittal, Francesca Battaglin, Yan Yang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 24, 2022
Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials
Jingyuan Wang, Yi Xiao, Fotios Loupakis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 7, 2012
Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features
Daniel T Chang, Rish K Pai, Lisa A Rybicki, et al.
Oncogene
|
January 17, 2023
Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions
Priya Jayachandran, Francesca Battaglin, Carly Strelez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 2022
Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer
Giacomo Mazzoli, Romain Cohen, Sara Lonardi, et al.
Journal for Immunotherapy of Cancer
|
January 2, 2023
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer
Vincenzo Nasca, Francesco Barretta, Francesca Corti, et al.
Journal for Immunotherapy of Cancer
|
January 4, 2025
Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors
Julien Taieb, Margherita Ambrosini, Emily Alouani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 29, 2021
Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women
Jyoti S Mathad, Rada Savic, Paula Britto, et al.
Page
of 6